Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000233697 | SCV000287133 | benign | X-linked myopathy with postural muscle atrophy | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000354542 | SCV000336631 | likely benign | not specified | 2015-11-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529694 | SCV000732446 | likely benign | not provided | 2020-11-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002378984 | SCV002671181 | likely benign | Cardiovascular phenotype | 2019-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001529694 | SCV005206802 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001529694 | SCV001743584 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001529694 | SCV001924300 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529694 | SCV001929871 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529694 | SCV001957139 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529694 | SCV001970949 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003967629 | SCV004778525 | likely benign | FHL1-related disorder | 2021-05-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |